The importance of determining circadian parameters in pharmacological studies

British Journal of Pharmacology - Tập 176 Số 16 - Trang 2827-2847 - 2019
Laetitia S. Gaspar1,2, Ana Rita Álvaro1,1, Sara Carmo‐Silva1,1, A.F. Mendes1,3, Angela Relόgio4,5, Cláudia Cavadas1,3
1Center for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
2Institute for Interdisciplinary Research (IIIUC), University of Coimbra, Coimbra, Portugal
3Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal
4Institute for Theoretical Biology Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt—Universität zu Berlin, and Berlin Institute of Health Berlin Germany
5Medical Department of Hematology, Oncology, and Tumor Immunology, Molecular Cancer Research Center Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt—Universität zu Berlin, and Berlin Institute of Health Berlin Germany

Tóm tắt

In mammals, most molecular and cellular processes show circadian changes, leading to daily variations in physiology and ultimately in behaviour. Such daily variations induce a temporal coordination of processes that is essential to ensure homeostasis and health. Thus, it is of no surprise that pharmacokinetics (PK) and pharmacodynamics (PD) of many drugs are also subject to circadian variations, profoundly affecting their efficacy and tolerability. Understanding how circadian rhythms influence drug PK, PD, and toxicity might significantly improve treatment efficacy and decrease related side effects. Therefore, it is essential to take circadian variations into account and to determine circadian parameters in pharmacological studies, especially when drugs have a short half‐life or target rhythmic processes. This review provides an overview of the current knowledge on circadian rhythms and their relevance to the field of pharmacology. Methodologies to evaluate circadian rhythms in vitro, in rodent models and in humans, from experimental to computational approaches, are described and discussed. Lastly, we aim at alerting the scientific, medical, and regulatory communities to the relevance of the physiological time, as a key parameter to be considered when designing pharmacological studies. This will eventually lead to more successful preclinical and clinical trials and pave the way to a more personalized treatment to the benefit of the patients.

Từ khóa


Tài liệu tham khảo

10.1016/j.cmet.2016.09.014

Akashi M., 2000, Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock, Genes & Development, 14, 645, 10.1101/gad.14.6.645

10.1073/pnas.1003878107

10.1016/j.neuron.2012.04.006

10.1111/bph.13878

10.1111/bph.13880

10.1111/bph.13877

10.1111/bph.13883

10.1093/sleep/26.3.342

10.1016/j.molcel.2017.07.017

10.1016/j.cell.2010.08.016

10.1016/j.cmet.2011.01.006

10.3389/fnbeh.2016.00106

10.1016/j.jneumeth.2017.04.014

10.1124/pr.116.013441

10.1126/science.289.5488.2344

10.1016/S0092-8674(00)81199-X

10.1016/S0960-9822(00)00758-2

10.1517/17425255.4.2.175

10.1126/science.aah4965

10.1042/bse0490103

10.1016/j.acthis.2014.07.001

10.1126/science.1169657

10.1073/pnas.1800314115

10.1371/journal.pbio.0030338

10.1016/S0960-9822(02)01145-4

10.1210/me.2006-0052

10.3389/fphar.2015.00071

10.1016/j.molmed.2016.03.004

10.1101/gad.183500

10.1093/embo-reports/kve007

10.1146/annurev-physiol-021909-135821

10.1016/j.yjmcc.2017.08.009

10.1158/1535-7163.MCT-15-0129

10.1002/9780470942390.mo140229

10.1016/j.ebiom.2018.06.012

10.1371/journal.pbio.2002940

10.1016/j.cels.2018.03.006

10.1101/gad.239327.114

Evans J. A., 2013, Progress in molecular biology and translational science, 283

Fang M., 2017, In vitro bioluminescence assay to characterize circadian rhythm in mammary epithelial cells, Journal of Visualized Experiments, 127, 1

10.1016/j.csbj.2015.07.001

10.1016/j.ebiom.2018.07.002

10.1016/j.cmet.2006.04.015

10.1111/liv.13525

10.1016/j.cell.2012.12.027

10.1101/sqb.2007.72.004

10.3389/fneur.2017.00100

10.1101/gad.284828.116

10.1016/j.joca.2015.02.020

10.1096/fj.201600353R

10.1093/nar/gkx1121

10.1016/j.smrv.2012.08.003

10.1074/jbc.M206233200

10.1101/gad.319228.118

10.1177/0748730418803719

10.1111/j.1471-4159.2008.05520.x

10.1177/0748730417728663

10.1177/0748730410379711

10.1186/s13073-017-0406-4

10.1177/0748730416668049

10.1093/nar/gkw030

10.1002/bies.201500026

10.1002/cam4.1711

10.1371/journal.pcbi.0020136

10.1038/nature02724

10.1080/07420528.2017.1338716

10.1038/nrm2503

10.1016/j.cca.2011.05.014

10.1073/pnas.0906361106

10.1016/j.brainres.2011.10.037

10.1101/gad.1432206

10.1177/0748730406294316

10.1371/journal.pone.0126283

10.1016/S0006-8993(02)04084-2

10.1146/annurev.pharmtox.47.120505.105208

10.1074/jbc.273.52.34970

10.1080/07420520902929029

10.1016/S0896-6273(00)80876-4

10.1038/nature09253

10.1038/s41598-018-33195-3

10.1016/j.cub.2015.02.032

10.1210/endo.138.2.4925

10.1073/pnas.1717735115

10.1146/annurev-neuro-060909-153128

10.1530/ror.0.0010153

10.1126/science.aao0318

10.3389/fphar.2015.00029

10.1001/jamaneurol.2017.4719

10.1007/978-3-642-25950-0_10

10.1016/j.cell.2004.11.015

10.1186/1471-2199-7-5

10.1126/science.1170803

10.1371/journal.pone.0037093

10.1016/0006-8993(79)90156-2

10.1007/s00424-017-2103-y

10.1126/science.2305266

Ramanathan C., 2012, Monitoring cell‐autonomous circadian clock rhythms of gene expression using luciferase bioluminescence reporters, Journal of Visualized Experiments, 27, 1

10.3389/fneur.2015.00128

10.1007/BF00215118

10.1371/journal.pgen.1004338

10.1371/journal.pcbi.1002309

10.1016/j.cub.2015.01.056

10.1007/978-3-642-25950-0_13

10.1016/j.cub.2016.04.011

10.1155/2017/2057168

10.1016/j.niox.2008.07.005

10.1073/pnas.0609625104

10.1126/scitranslmed.aat8806

10.3389/fneur.2015.00095

10.1101/gad.221374.113

10.1101/gad.183251.111

10.1074/jbc.273.42.27039

10.1007/s00018-012-1026-1

10.1016/j.cell.2017.07.042

10.1159/000336664

10.1016/j.bbabio.2016.03.035

10.1016/j.addr.2007.07.001

10.1016/j.psyneuen.2016.09.026

10.2147/JIR.S155903

10.1073/pnas.1206274109

10.1073/pnas.69.6.1583

10.1152/ajplegacy.1898.1.1.40

10.1016/j.tips.2018.07.003

10.1016/j.cub.2012.04.009

10.1038/nrg.2016.150

10.1038/nrg2430

10.15252/emmm.201708724

10.7150/ijbs.26518

10.1093/bioinformatics/btw309

Tilstra J. S., 2011, NF‐κB in aging and disease, Aging and Disease, 2, 449

10.1038/nprot.2006.37

10.1126/science.1108750

10.1038/ng1504

10.1126/science.137.3535.1058

10.1101/gad.397006

10.1016/j.cmet.2016.10.003

10.1038/s41598-016-0001-8

Wang Y., 2018, Disruption of the circadian clock alters antioxidative defense via the SIRT1–BMAL1 pathway in 6‐OHDA‐induced models of Parkinson's disease, Oxidative Medicine and Cellular Longevity, 2018, 1, 10.1155/2018/4854732

10.1016/j.bbrc.2012.08.008

10.1016/S0076-6879(05)93011-5

10.1016/0896-6273(95)90214-7

10.1101/pdb.err072298

10.1146/annurev-physiol-021909-135919

10.1016/j.cub.2004.11.057

10.1016/S0962-8924(98)01433-0

10.1172/JCI120874

10.1016/S0014-5793(99)01724-X

10.1126/science.1059542

10.1126/science.1089287

10.1038/35055628

10.1016/S0960-9822(00)00602-3

10.1177/0748730415621412

10.1016/j.cels.2018.01.013

10.1038/sj.emboj.7600244

10.1073/pnas.0308709101

10.1016/j.cell.2009.08.031

10.1073/pnas.1408886111

10.1097/MCO.0000000000000065